Ovarian cancer in primary care

Author:

Maxwell Susanne Sarah12ORCID,Yan Xiangfei3,May James4,Weller David1

Affiliation:

1. Centre for Population Health Sciences, University of Edinburgh, Edinburgh

2. Email:

3. Edinburgh Cancer Centre, Edinburgh

4. The Simpson Centre for Reproductive Medicine, Gynaecology Oncology Unit, Royal Infirmary of Edinburgh, University Hospitals of Edinburgh, Edinburgh

Abstract

Ovarian cancer continues to be the leading cause of gynaecological cancer death in the UK. It has previously been described as the ‘silent killer’, as symptoms are typically absent or non-specific early in the disease leading to a later stage at diagnosis where fewer treatment options are available. Stage at presentation influences patient survival, and therefore, early detection within primary care is vital. Currently, there is no screening programme for ovarian cancer, and so diagnosis relies on investigation of symptomatic women presenting to healthcare professionals and an awareness of vague symptoms that could indicate ovarian cancer pathology. This article aims to provide an overview of ovarian cancer, including epidemiology, risk factors, signs and symptoms, and diagnosis within primary care. We will also briefly discuss current treatment strategies for ovarian cancer.

Publisher

SAGE Publications

Subject

General Earth and Planetary Sciences,General Environmental Science

Reference25 articles.

1. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study

2. Cancer Research UK (2018) Ovarian cancer statistics. Available at: www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/ovarian-cancer (accessed October 2021).

3. Centers for Disease Control and Prevention (2020) Hereditory breast and ovarian cancer: BRAC1 and BRAC2 genes. Available at: www.cdc.gov/genomics/disease/breast_ovarian_cancer/genes_hboc.htm (accessed 8 Decemer 2021).

4. Ovarian cancer symptoms, routes to diagnosis and survival – Population cohort study in the ‘no screen’ arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

5. Communicating with patients and families about illness progression and end of life: a review of studies using direct observation of clinical practice

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3